Universal Technical Institute, Inc. (UTI)
NYSE: UTI · Real-Time Price · USD
27.13
-6.29 (-18.82%)
Aug 7, 2025, 4:00 PM - Market closed
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $34.83, which forecasts a 28.38% increase in the stock price over the next year. The lowest target is $25 and the highest is $40.
Price Target: $34.83 (+28.38%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rosenblatt | Rosenblatt | Strong Buy Maintains $36 | Strong Buy | Maintains | $36 | +32.69% | Aug 7, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $36 | Buy | Maintains | $36 | +32.69% | Jul 29, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $36 | Buy | Maintains | $36 | +32.69% | Jun 12, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $37 → $40 | Strong Buy | Maintains | $37 → $40 | +47.44% | May 22, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $35 → $38 | Strong Buy | Maintains | $35 → $38 | +40.07% | May 21, 2025 |
Financial Forecast
Revenue This Year
837.72M
from 732.69M
Increased by 14.34%
Revenue Next Year
904.92M
from 837.72M
Increased by 8.02%
EPS This Year
1.06
from 0.75
Increased by 40.82%
EPS Next Year
1.08
from 1.06
Increased by 2.49%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 872.8M | 953.2M | 1.0B |
| Avg | 837.7M | 904.9M | 969.7M |
| Low | 808.5M | 868.3M | 940.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 19.1% | 13.8% | 11.4% |
| Avg | 14.3% | 8.0% | 7.2% |
| Low | 10.3% | 3.6% | 4.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.12 | 1.29 | 1.26 |
| Avg | 1.06 | 1.08 | 1.21 |
| Low | 0.99 | 0.93 | 1.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 49.8% | 22.3% | 16.4% |
| Avg | 40.8% | 2.5% | 12.0% |
| Low | 32.0% | -11.9% | 8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.